Download MendeleyLigand-protein interactions of selective casein kinase 1 delta inhibitors.
Mente, S., Arnold, E., Butler, T., Chakrapani, S., Chandrasekaran, R., Cherry, K., Dirico, K., Doran, A., Fisher, K., Galatsis, P., Green, M., Hayward, M., Humphrey, J., Knafels, J., Li, J., Liu, S., Marconi, M., McDonald, S., Ohren, J., Paradis, V., Sneed, B., Walton, K., Wager, T.(2013) J Med Chem 56: 6819-6828
- PubMed: 23919824 Search on PubMed
- DOI: https://doi.org/10.1021/jm4006324
- Primary Citation Related Structures:
4KB8, 4KBA, 4KBC, 4KBK - PubMed Abstract:
Casein kinase 1δ (CK1δ) and 1ε (CK1ε) are believed to be necessary enzymes for the regulation of circadian rhythms in all mammals. On the basis of our previously published work demonstrating a CK1ε-preferring compound to be an ineffective circadian clock modulator, we have synthesized a series of pyrazole-substitued pyridine inhibitors, selective for the CK1δ isoform. Additionally, using structure-based drug design, we have been able to exploit differences in the hinge region between CK1δ and p38 to find selective inhibitors that have minimal p38 activity. The SAR, brain exposure, and the effect of these inhibitors on mouse circadian rhythms are described. The in vivo evaluation of these inhibitors demonstrates that selective inhibition of CK1δ at sufficient central exposure levels is capable of modulating circadian rhythms.
- Pfizer Worldwide Research and Development , 700 Main Street, Cambridge, Massachusetts 02139, United States.
Organizational Affiliation:
